The University of Colorado Cancer Center and other clinical trial institutions are reporting on promising results in clinical trials of the anti-cancer drug ONT-380 at the annual meeting of the American Society of Clinical Oncology this weekend in Chicago.
from Denver Post: News: Breaking: Local http://ift.tt/1ADotAx
via Cherry Creek
No comments:
Post a Comment